EternaTear
Dr. Stone was the VP of Consumer R&D at Alcon/Novartis where he developed and launched over 15 ophthalmic products including the Systane® dry eye artificial tear product line. A PhD chemist by training, Ralph has 35 years of ophthalmic R&D experience and is a recognized FDA expert in the field of ophthalmology. Ralph holds degrees from Middlebury and Bowdoin was well as a Ph.D. in Chemistry from the University of Vermont.
This person is not in any offices
EternaTear
1 followers
EternaTear is developing a next-generation therapy for the over-the-counter dry eye market.